TG Therapeutics TGTX Warrants Issued With Debt Financing Noncash
Warrants Issued With Debt Financing Noncash at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept tgtx:WarrantsIssuedWithDebtFinancingNoncash.
The official record: TG Therapeutics’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's warrants issued with debt financing noncash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is TG Therapeutics's warrants issued with debt financing noncash?
- TG Therapeutics (TGTX) reported warrants issued with debt financing noncash of $0 in Q4 2025.
- What does warrants issued with debt financing noncash mean?
- The non-cash value of warrants granted to lenders as part of a debt financing deal.
- How do you interpret warrants issued with debt financing noncash?
- An increase indicates the use of equity-linked instruments to lower cash interest costs or incentivize lenders, which may lead to future dilution.
- How does warrants issued with debt financing noncash compare across companies?
- Often seen in growth-stage or distressed companies utilizing complex financing structures.